Masoud Vedadi - Concepedia

Author

Masoud Vedadi

Also Known As

Allali-Hassani, Abdellah, Brown, Peter J., C.H. Arrowsmith, Frye, Stephen V., Huang, Xi-ping, Liu, Feng, Loppnau, Peter, M Vedadi, M. VEDADI, M. Vedadi

398

Publications

18.4K

Citations

H-Index

Concepts

All Affiliations

University of Toronto Structural Genomics Consortium Princess Margaret Cancer Centre Ontario Institute for Cancer Research University of North Carolina at Chapel Hill

About

Masoud Vedadi is an author at University of Toronto specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	67	11K
2	Natural Sciences	45	62	10.3K
3	Biochemistry	38	48	8.3K
4	Engineering	4	4	560
5	Biology	1	1	235

Masoud Vedadi

163

Publications

17.5K

Citations

H-Index

Page 1

	Year	Citations
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability F. Niesen, H. Berglund, Masoud Vedadi Nature Protocols Protein ChemistryProtein StabilityBiochemistryProtein AssemblyProtein Folding	2007	2.4K
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination Masoud Vedadi, F. Niesen, Abdellah Allali‐Hassani, Proceedings of the National Academy of Sciences New LigandsProtein AssemblyMolecular BiologyChemical BiologyProtein Crystallization	2006	589
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells Masoud Vedadi, Dalia Baršytė-Lovejoy, Feng Liu, Nature Chemical Biology Signal TransductionCellular EnzymologyBiochemistryG Protein-coupled ReceptorMedicine	2011	527
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth Jiajun Zhu, Morgan A. Sammons, Greg Donahue, Nature Cancer ResearchChromatinChromatin RemodelingMedicineCancer Growth	2015	482
An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1 Kyle D. Konze, Anqi Ma, Fengling Li, ACS Chemical Biology Histone ModificationsEpigenetic ChangeMolecular BiologyChemical BiologyCancer Biology	2013	464
A Strategy for Modulation of Enzymes in the Ubiquitin System Andreas Ernst, G.V. Avvakumov, Jiefei Tong, Science Ubiquitin VariantsProtein ChemistryProtein FunctionAldo-keto ReductaseCellular Enzymology	2013	295
Recognition and Specificity Determinants of the Human Cbx Chromodomains Lilia Kaustov, Hui Ouyang, M.F. Amaya, Journal of Biological Chemistry Histone ModificationsEpigenetic ChangeGeneticsBlood CellPathology	2010	295
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors Wenyu Yu, Emma J. Chory, Amy K. Wernimont, Nature Communications BiochemistryNatural SciencesBiocatalysisCatalytic Site RemodellingEnzyme Catalysis	2012	283
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia Florian Grebien, Masoud Vedadi, Matthäus Getlik, Nature Chemical Biology Hematological MalignancyMedicinePharmacologyCancer BiologyCell Biology	2015	282
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases Mohammad S. Eram, Yudao Shen, Magdalena M. Szewczyk, ACS Chemical Biology Drug TargetEpigenetic ChangeMolecular BiologyType Iii PrmtsChemical Biology	2015	280

Page 1